Janusz J. Kulagowski

Author

Also Known As

J J Kulagowski, J. J. KULAGOWSKI, J. J. Kulagowski, J. Kulagowski, J.J. Kulagowski, Jan J. Kulagowski, Janusz J Kulagowski, Janusz J. Kulagowski, Janusz Kulagowski, Kulagowski, J.J.

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

MSD (UK) Limited (United Kingdom)Merck & Co., Inc., Rahway, NJ, USA (United States)Loughborough University

About

Janusz J. Kulagowski is an author at MSD (UK) Limited (United Kingdom) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	29	1.9K
2	Biochemistry	22	26	1.5K
3	Natural Sciences	17	20	1.1K
4	Engineering	11	11	427
5	Social Sciences	4	4	585

Janusz J. Kulagowski

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine: An Antagonist with High Affinity and Selectivity for the Human Dopamine D<sub>4</sub> Receptor Janusz J. Kulagowski, Howard B. Broughton, Neil R. Curtis, Journal of Medicinal Chemistry Altmetric Attention ScorePsychopharmacologyPharmacotherapySocial SciencesMolecular Pharmacology	1996	257
Role of Dopamine D2-like Receptors in Cocaine Self-Administration: Studies with D2 Receptor Mutant Mice and Novel D2 Receptor Antagonists S. Barak Caine, S. Stevens Negus, Nancy K. Mello, Journal of Neuroscience	2002	230
Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression Martin R. Guscott, Linda J. Bristow, Karen L. Hadingham, Neuropharmacology PsychiatryFunctional SelectivityMedicinePsychotropic MedicationPharmacological Blockade Studies	2005	227
Biological Profile of L-745,870, a Selective Antagonist with High Affinity for the Dopamine D4 Receptor Smita S. Patel, Stephen B. Freedman, Kerry L. Chapman, Journal of Pharmacology and Experimental Therapeutics	1997	165
3'-(Arylmethyl)- and 3'-(Aryloxy)-3-phenyl-4-hydroxyquinolin- 2(1H)-ones: Orally Active Antagonists of the Glycine Site on the NMDA Receptor Janusz J. Kulagowski, R. BAKER, Neil R. Curtis Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapyExperimental PharmacologyPharmaceutical ChemistryActive Antagonists	1994	139
Effect of Plasma Protein Binding on in Vivo Activity and Brain Penetration of Glycine/NMDA Receptor Antagonists Michael Rowley, Janusz J. Kulagowski, Alan P. Watt, Journal of Medicinal Chemistry Brain PenetrationGlycine/nmda Receptor AntagonistsPharmacotherapyExperimental PharmacologyHplc Assay	1997	129
A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective Inhibitors Sue J. Sohn, Kathy Barrett, Anne van Abbema, The Journal of Immunology T-regulatory CellImmunologyImmune RegulationCell DeathImmunologic Mechanism	2013	123
L-745,870, a Subtype Selective Dopamine D4 Receptor Antagonist, Does Not Exhibit a Neuroleptic-Like Profile in Rodent Behavioral Tests Linda J. Bristow, Neil Collinson, Gina P Cook, Journal of Pharmacology and Experimental Therapeutics	1997	105
The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor Martin R. Guscott, E. Egan, G.P. Cook, Neuropharmacology 5-Ht7 ReceptorMolecular PhysiologyNeurophysiologyMedicinePhysiology	2003	99
Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors Janusz J. Kulagowski, Wade Blair, Richard J. Bull, Journal of Medicinal Chemistry RheumatologyMedicinal ChemistryDrug TargetBiochemistryMedicine	2012	91

Page 1